EquityBulls

Latest News

Keywords Selected: INE089A01023

Research

Dr. Reddy's Laboratories - Analyst Meet Update - Multiple growth initiatives - BUY

Stock Report

Dr. Reddy's Laboratories launches Difluprednate Ophthalmic Emulsion 0.05% in the U.S. Market
Dr. Reddy's successfully completes full set of clinical studies of its rituximab biosimilar for filing in the U.S., Europe
Dr. Reddy's launches in-house palbociclib to widen access to high-quality breast cancer drug
Dr. Reddys Laboratories Ltd updates on litigation
Dr. Reddy's successfully completes Phase 1 study of DRL_TC, a proposed biosimilar of tocilizumab
Dr. Reddy's Research and Development BV to sell certain assets at Leiden, The Netherlands
Aurigene reports results of AUR101 in Phase II Study in Patients with moderate to severe psoriasis
Dr. Reddy's Laboratories Ltd updates on antitrust litigation
Dr. Reddy's Laboratories enters into a licensing agreement with Slayback Pharma
Dr. Reddy's Laboratories launches Bortezomib for Injection, 3.5 mg Single-Dose Vial in the U.S. Market
Dr. Reddy's announces the first-to-market launch of over-the-counter, store-brand equivalent of Allegra-D® 24 HR in the U.S. Market
Dr. Reddy's Labs launches Fesoterodine Fumarate Extended-Release Tablets in the U.S. market
Dr. Reddy's Laboratories updates on PAI of formulations facility
Dr. Reddy's Laboratories announces conclusion of patent litigation with Indivior Inc
Dr. Reddy's Laboratories announces the acquisition of an injectable product portfolio from Eton Pharma
Dr. Reddy's Laboratories Limited enters into settlement agreement with Indivior Inc
Dr. Reddy's Laboratories announces launch of the generic version of Nexavar in the U.S. market
Olema Oncology and Aurigene Announce Exclusive Collaboration and License Agreement to Discover and Develop Novel Cancer Therapies
Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. announces the launch Ketorolac Tromethamine Tablets USP, 10 mg in the U.S. market
Dr. Reddys Laboratories Ltd recommends final dividend of Rs. 30
Dr. Reddy's Laboratories enters into exclusive partnership with HK inno.N Corporation
Dr. Reddy's Laboratories announces the launch of Posaconazole Delayed-Release Tablets in the U.S. Market
Dr. Reddy's to acquire cardiovascular brand Cidmus® in India
Dr. Reddy's Laboratories updates on acquisition of Nimbus Health GmbH